Xarelto the Target of Wrongful Death Lawsuit
The family of a man in Vermont who died in August 2012 has filed a wrongful death lawsuit against the drug company Xarelto. The man died after fewer than 10 days of using the drug, and the family believes that Xarelto is liable for his death.
Xarelto is the brand name of a rivaroxaban drug used to reduce the risk of conditions like deep vein thrombosis and pulmonary embolus, conditions that commonly arise after knee or hip replacement surgery. It is also used to reduce the risk of stroke in people with abnormal heart rhythms. In this case, the deceased was prescribed the drug for the latter purpose — to reduce risk of a stroke while he was being treated for atrial fibrillation.
The drug has been shown to have various side effects, including bleeding. In Xarelto, the bleeding side effect and the drug do not have an approval reversal agent that would stop the effect of blood thinning, unlike a similar drug, warfarin. Xarelto was marketed as a preferable alternative to warfarin, which generated huge numbers in sales over the last couple years.
In the lawsuit, the family of the victim alleges that Xarelto withheld the information regarding a lack of antidote for the effect, and that the fatal hemorrhage he suffered was a direct result of side effects of the drug. In the language of the lawsuit, the family accuses Xarelto higher-ups of putting profits before safety in the medication.
These are serious allegations, and if you or a loved one has suffered from life-threatening symptoms while taking Xarelto or any other prescription drug, it’s important to speak with a skilled personal injury lawyer at McMenamy Law LLC in Atlanta.